Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
The AI technology used to examine Mr Studholme's scan belongs to Israeli company Nanox.AI, which is one of only a handful of ...
Are you due for a bone density test? The U.S. Preventive Services Task Force announced updated osteoporosis screening ...
Fifty per cent of women and 20 per cent of men will break a bone due to osteoporosis in their lifetime, according to the ...
The Spanish Association with Osteoporosis and Osteoarthritis (AECOSAR) and the Osteoarthritis Foundation International (OAFI) ...
Number 4: Celltrion’s denosumab biosimilar demonstrated equivalent efficacy, safety, and immunogenicity compared with the ...
The Mor Institute, part of Clalit Health Services, is Israel's leading network of diagnostic medical centers, with 23 branches nationwide serving over one million patients annually. The new Be'er ...
The comedian revealed her diagnosis in February 2024 after internet sleuths pointed out she had “moon face,” a common symptom ...
Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...
Researchers are exploring how to prolong ovarian life and revisiting hormone replacement therapy — a once routine treatment ...
There could be “deadly consequences” if the NHS cuts a “critical” target for patients with a learning disability, a charity has warned. Every year, health leaders in England publish national planning ...
Treatment with the highest dose of investigational injectable amycretin -- a unimolecular GLP-1 and amylin receptor agonist -- yielded a 22% weight loss after 36 weeks in a phase Ib/IIa trial, said ...